FDA Inspection
UCSF Radiopharmaceutical FacilityUCSF Radiopharmaceutical Facility – FDA Inspection, Jul 24, 2025
Record Details
This FDA Inspection record concerns UCSF Radiopharmaceutical Facility, with an inspection on July 24, 2025, issued by the San Francisco District Office, covering human drugs.
View Company Profile
ID · 550f1324-df5b-43b2-92a5-5b6b29f47972
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1276699
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 212.70(c)Conform to specs prior to release
- 21 CFR 212.20(e)Written QA procedures established, followed
- 21 CFR 212.50(a)Written control procedures
- 21 CFR 212.50Adequate controls (general)
Full citation text and observation details available on the Dashboard.
Other FDA inspections of UCSF Radiopharmaceutical Facility
2| Date | Classification | Office | Project area |
|---|---|---|---|
| July 24, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 5, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for UCSF Radiopharmaceutical Facility
- FDA Inspection 1125294 - 2020-07-24
- FDA Inspection 947424 - 2015-11-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.